Development and evaluation of an improved quantitative Y-90 bremsstrahlung SPECT method
Purpose: Yttrium-90 (Y-90) is one of the most commonly used radionuclides in targeted radionuclide therapy (TRT). Since it decays with essentially no gamma photon emissions, surrogate radionuclides (e.g., In-111) or imaging agents (e.g., Tc-99m MAA) are typically used for treatment planning. It would, however, be useful to image Y-90 directly in order to confirm that the distributions measured wit